Andrographolide sensitizes KRAS-mutant colorectal cancer cells to cetuximab by inhibiting the EGFR/AKT and PDGFRβ/AKT signaling pathways
Yanfei Liu, Zhiqiang Feng, Tianhao Chu, Ben Yi, Jun Liu, Haiyang Yu, Jun Xue, Yijia Wang, Chunze Zhang
Topics & Concepts
CetuximabKRASProtein kinase BCancer researchPI3K/AKT/mTOR pathwayWnt signaling pathwayMedicineColorectal cancerCancerSignal transductionBiologyInternal medicineCell biologyAndrographolide Research and ApplicationsTraditional Chinese Medicine AnalysisBerberine and alkaloids research